Literature DB >> 31079692

Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.

Stefania Paolillo1, Fabio Marsico2, Maria Prastaro3, Francesco Renga3, Luca Esposito3, Fabiana De Martino3, Pierfrancesco Di Napoli3, Immacolata Esposito3, Antonio Ambrosio3, Monica Ianniruberto3, Rosa Mennella3, Roberta Paolillo3, Paola Gargiulo4.   

Abstract

A strict bidirectional relationship exists between diabetes mellitus and heart failure. Diabetic cardiomyopathy is a specific cardiac manifestation of patients with diabetes characterized by left ventricular hypertrophy and diastolic dysfunction in the early phase up to overt heart failure with reduced systolic function in the advanced stages. The pathogenesis of this condition is multifactorial and recognizes as main promoting factors the presence of insulin resistance and hyperglycemia. Diabetic cardiomyopathy exerts a negative prognostic impact in affected patients and no target treatments are currently available. More efforts are needed to better define the diagnostic and therapeutic approach in this specific setting.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Diabetic cardiomyopathy; Diastolic dysfunction; Heart failure; Systolic dysfunction

Mesh:

Year:  2019        PMID: 31079692     DOI: 10.1016/j.hfc.2019.02.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  40 in total

1.  Characteristics of Myocardial Perfusion in Type 2 Diabetes Mellitus and Its Association with Left Ventricular Diastolic Dysfunction: A Study of Myocardial Contrast Echocardiography.

Authors:  Yi Liu; Jing Ma; Jia Guo; Hao Lu; Yan Zhang; Yilei Chen
Journal:  Int J Gen Med       Date:  2021-11-02

2.  Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor of Receptor Interacting Protein Kinase 3 Alleviates Necroptosis in Glycation End Products-Induced Cardiomyocytes Injury.

Authors:  Yuyun Hua; Jianan Qian; Ji Cao; Xue Wang; Wei Zhang; Jingjing Zhang
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 3.  Sodium-glucose co-transporter 2 inhibitors and heart failure-the present and the future.

Authors:  Melanie Nana; Holly Morgan; L N Rao Bondugulapati
Journal:  Heart Fail Rev       Date:  2021-07       Impact factor: 4.214

4.  Guan Xin Dan Shen formulation protects db/db mice against diabetic cardiomyopathy via activation of Nrf2 signaling.

Authors:  Bin Zhang; Chen-Yang Zhang; Xue-Lian Zhang; Gui-Bo Sun; Xiao-Bo Sun
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

5.  Inhibiting Glucose Metabolism By miR-34a and miR-125b Protects Against Hyperglycemia-Induced Cardiomyocyte Cell Death.

Authors:  Chao-Rui Xu; Qiu-Ju Fang
Journal:  Arq Bras Cardiol       Date:  2021-03       Impact factor: 2.000

6.  Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy.

Authors:  Shin-Ichi Oka; Jaemin Byun; Chun-Yang Huang; Nobushige Imai; Guersom Ralda; Peiyong Zhai; Xiaoyong Xu; Sanchita Kashyap; Junco S Warren; John Alan Maschek; Trevor S Tippetts; Mingming Tong; Sundararajan Venkatesh; Yoshiyuki Ikeda; Wataru Mizushima; Toshihide Kashihara; Junichi Sadoshima
Journal:  Circ Res       Date:  2021-04-30       Impact factor: 23.213

7.  HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress.

Authors:  Donglin Chen; Xiang Ruan; Yu Liu; Yan He
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

8.  Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation.

Authors:  Shu Song; Yue Ding; Guo-Liang Dai; Yue Zhang; Meng-Ting Xu; Jie-Ru Shen; Ting-Ting Chen; Yun Chen; Guo-Liang Meng
Journal:  Acta Pharmacol Sin       Date:  2020-08-07       Impact factor: 6.150

Review 9.  The Potential Role of Flavonoids in Ameliorating Diabetic Cardiomyopathy via Alleviation of Cardiac Oxidative Stress, Inflammation and Apoptosis.

Authors:  Fatin Farhana Jubaidi; Satirah Zainalabidin; Izatus Shima Taib; Zariyantey Abd Hamid; Siti Balkis Budin
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

Review 10.  The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms.

Authors:  Teresa Salvatore; Pia Clara Pafundi; Raffaele Galiero; Gaetana Albanese; Anna Di Martino; Alfredo Caturano; Erica Vetrano; Luca Rinaldi; Ferdinando Carlo Sasso
Journal:  Front Med (Lausanne)       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.